1. Home
  2. SHC vs RYTM Comparison

SHC vs RYTM Comparison

Compare SHC & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$15.35

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$84.16

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHC
RYTM
Founded
2015
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.9B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
SHC
RYTM
Price
$15.35
$84.16
Analyst Decision
Buy
Strong Buy
Analyst Count
7
14
Target Price
$20.67
$131.14
AVG Volume (30 Days)
2.6M
960.8K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
68.75
28.34
EPS
0.27
N/A
Revenue
$1,163,617,000.00
N/A
Revenue This Year
$7.51
$54.90
Revenue Next Year
$6.00
$86.58
P/E Ratio
$56.91
N/A
Revenue Growth
5.74
N/A
52 Week Low
$10.17
$55.31
52 Week High
$19.85
$122.20

Technical Indicators

Market Signals
Indicator
SHC
RYTM
Relative Strength Index (RSI) 58.45 44.36
Support Level $15.19 $74.50
Resistance Level $16.55 $93.51
Average True Range (ATR) 0.43 4.53
MACD 0.30 0.72
Stochastic Oscillator 95.94 57.76

Price Performance

Historical Comparison
SHC
RYTM

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: